Amir A Rahnemai-Azar
Overview
Explore the profile of Amir A Rahnemai-Azar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pyreddy S, Kim S, Miyamoto W, Talib Z, GnanaDev D, Rahnemai-Azar A
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075698
Esophageal cancer is one of the most common and deadliest cancers worldwide. Rates of esophageal cancer worldwide have been steadily rising over the past decade due to higher incidence of...
2.
Rahnemai-Azar A, Selby L, Lustberg M, Pawlik T
Hematol Oncol Clin North Am
. 2024 Nov;
39(1):25-35.
PMID: 39510675
Hepatic resection for patients with isolated breast cancer liver metastases (BCLM) is associated with prolonged disease-free interval and better overall survival in highly selected patients. Patients with limited disease who...
3.
Matsumoto R, Verna E, Rosenblatt R, Emond J, Brown Jr R, Rahnemai-Azar A, et al.
Transplantation
. 2024 Apr;
108(10):2100-2108.
PMID: 38622762
Background: Although post liver transplant survival rates have significantly improved during the past 2-3 decades, the trend in intention-to-treat (ITT) survival (survival from waitlist addition) has not been well studied....
4.
Speckart J, Rasmusen V, Talib Z, GnanaDev D, Rahnemai-Azar A
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339363
Cholangiocarcinoma is a heterogeneous group of biliary tract cancers that has a poor prognosis and globally increasing incidence and mortality. While surgical resection remains the only curative option for the...
5.
Lawal G, Xiao Y, Rahnemai-Azar A, Tsilimigras D, Kuang M, Bakopoulos A, et al.
Vaccines (Basel)
. 2021 Oct;
9(10).
PMID: 34696292
Liver cancer is the third leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. Liver resection or transplantation offer the...
6.
Hewitt D, Rahnemai-Azar A, Pawlik T
Expert Opin Investig Drugs
. 2021 Jun;
30(8):827-835.
PMID: 34102935
: Traditional systemic therapies offer limited benefit for advanced cancers of the liver. Immune checkpoints are inhibitory regulators of the immune system and the success of immune checkpoint inhibitors (ICIs)...
7.
Rahnemai-Azar A, Pawlik T
Expert Opin Investig Drugs
. 2021 Mar;
30(4):419-427.
PMID: 33645382
: Cholangiocarcinoma (CCA) is a diverse group of fatal malignancies arising from the biliary tract. Surgical resection with negative margin offers the only potentially curative option. The majority of patients...
8.
Limaye A, Rahnemai-Azar A, Nazarian S, Perkins J, Reyes J
Transplant Direct
. 2020 Dec;
7(1):e637.
PMID: 33324742
Methods: From January 3, 2009, to July 27, 2015, stored plasma from consecutive CMV seropositive liver donors was retrospectively tested for CMV viremia by PCR. From April 20, 2012, to...
9.
Rahnemai-Azar A, Selby L, Lustberg M, Pawlik T
Surg Oncol Clin N Am
. 2020 Nov;
30(1):27-37.
PMID: 33220807
Hepatic resection for patients with isolated breast cancer liver metastases (BCLM) is associated with prolonged disease-free interval and better overall survival in highly selected patients. Patients with limited disease who...
10.
Rahnemai-Azar A, Abbasi A, Acher A, Weber S, Pawlik T
Surg Oncol
. 2020 Aug;
35:47-55.
PMID: 32827952
Cholangiocarcinoma (CCA) is the second most common biliary tract malignancy with a dismal prognosis. Surgical resection with a negative microscopic margin offers the only hope for long-term survival. However, the...